Gurdal, E.E.Durmaz I.Cetin-Atalay, R.Yarim, M.2016-02-082016-02-08201514756366http://hdl.handle.net/11693/21381Synthesis, characterization and cytotoxic activities of ten benzothiazole-piperazine derivatives were reported. In vitro cytotoxic activities of compounds were screened against hepatocellular (HUH-7), breast (MCF-7) and colorectal (HCT-116) cancer cell lines by sulphorhodamine B assay. Based on the GI<inf>50</inf> values of the compounds, most of the benzothiazole-piperazine derivatives are active against HUH-7, MCF-7 and HCT-116 cancer cell lines. Compound 1d is highly cytotoxic against all tested cancer cell lines. Further investigation of compound 1d by Hoechst Staining and Fluorescence-Activated Cell Sorting Analysis (FACS) revealed that this compound causes apoptosis by cell cycle arrest at subG<inf>1</inf> phase. © 2014 Informa UK Ltd. All rights reserved.EnglishAnticancerbenzothiazolecytotoxicitypiperazinesulphorodamine Bantineoplastic agentbenzothiazole derivativefluorouraciln (6 ethoxybenzothiazol 2 yl) 2 [4 (o chlorophenyl)piperazinyl]acetamiden (6 ethoxybenzothiazol 2 yl) 2 [4 (o cyanophenyl)piperazinyl]acetamiden (6 ethoxybenzothiazol 2 yl) 2 [4 (p cyanophenyl)piperazinyl]acetamiden (6 ethoxybenzothiazol 2 yl) 2 [4 (p toluyl)piperazinyl]acetamiden (6 methylbenzothiazol 2 yl) 2 (4 cyclohexylpiperazinyl)acetamiden (6 methylbenzothiazol 2 yl) 2 [4 (2 methoxyethyl)piperazinyl]acetamiden (6 methylbenzothiazol 2 yl) 2 [4 (2 methoxyphenyl)piperazinyl]acetamiden (6 methylbenzothiazol 2 yl) 2 [4 (3,4 dichlorophenyl)piperazinyl]acetamiden (6 methylbenzothiazol 2 yl) 2 [4 (4 chlorobenzyl)piperazinyl]acetamiden (6 methylbenzothiazol 2 yl) 2 [4 (pyridin 4 yl)piperazinyl]acetamidepiperazine derivativesulforhodamine Bunclassified drugapoptosisArticlecancer cell linecell cycle arrestcell cycle G1 phasechemical structurecontrolled studydrug cytotoxicitydrug synthesisfluorescence activated cell sortinghumanhuman cellhuman cell culturein vitro studypriority journalproton nuclear magnetic resonanceCytotoxic activities of some benzothiazole-piperazine derivativesArticle10.3109/14756366.2014.959513